US authorizes AstraZeneca’s Evusheld for pre-exposure prevention of COVID-19
New Delhi, December 09 AstraZeneca’s Evusheld (Tixagevimab co-packaged with Cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation
Read more